comparemela.com

Latest Breaking News On - Antoniar sepulveda - Page 1 : comparemela.com

AMP s new consensus can promote standardization of PGx gene/allele testing, improve patient care

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP2D6 assays, promote standardization of testing across different laboratories and improve patient care

AMP recommends minimum set of pharmacogenetic alleles to guide clinical CYP2D6 genotype testing, pro

 E-Mail ROCKVILLE, Md. - June 10, 2021 - The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP2D6 assays, promote standardization of testing across different laboratories and improve patient care. The manuscript, Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and European Society for Pharmacogenomics and Personalized Therapy, was released online ahead of publication in The Journal of Molecular Diagnostics.

Latest Association for Molecular Pathology Survey Findings Indicate Significant Decline in Molecular Testing for Cancer During COVID-19 Pandemic

Latest association for molecular pathology survey findings indicate significant decline in molecula

New ACR Steering Committee established to guide diagnostic testing during COVID-19 pandemic

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today announced the formation of the AMP COVID Response (ACR) Steering Committee to help coordinate and communicate the organization's continued efforts to guide diagnostic testing during the ongoing COVID-19 pandemic and preparations for future emerging outbreaks.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.